Suppr超能文献

肿瘤激活型超小纳米酶发生器用于增强渗透和深层催化治疗。

Tumor-activatable ultrasmall nanozyme generator for enhanced penetration and deep catalytic therapy.

机构信息

Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China; University of Science and Technology of China, Hefei, Anhui, 230029, China.

Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China.

出版信息

Biomaterials. 2020 Nov;258:120263. doi: 10.1016/j.biomaterials.2020.120263. Epub 2020 Jul 31.

Abstract

Tumor-activatable ultrasmall nanozyme generation is an unprecedented strategy to overcome intrinsically fatal defects of traditional reactive oxygen species (ROS)-based nanoagents for deep tumor penetration, including limited tissue-penetrating depth of external energy, heavy reliance on oxygen and nonspecific toxicity of therapeutic agents. Here, based on the cascade reaction between glucose oxidase (GOx) and ultrasmall peroxidase nanozyme embedded into acid-dissociable zeolitic imidazolate framework-8 (ZIF-8), such a tumor-activatable ultrasmall nanozyme generator is designed for enhanced penetration and deep catalytic therapy. With the aid of mildly acidic tumor microenvironment, the produced gluconic acid from intratumoral glucose can gradually induce the dissociation of ZIF-8 to release ultrasmall peroxidase nanozyme with significant intratumoral penetration. On the other hand, the generated hydrogen peroxide with relatively long-life can be subsequently catalyzed by penetrated peroxidase nanozyme into toxic hydroxyl radicals for deep catalytic therapy. In this way, the well-designed nanoplatform not only can greatly enhance tumor penetration but also directly induce exogenous ROS without oxygen participation and external energy input, thereby thoroughly avoiding the inactivation of traditional ROS-based nanoagents in the extremely hypoxic tumor center and finally resulting in remarkable deep catalytic therapy.

摘要

肿瘤激活型超小纳米酶的产生是克服传统基于活性氧(ROS)的纳米制剂在深层肿瘤穿透方面固有致命缺陷的一种前所未有的策略,这些缺陷包括外部能量的组织穿透深度有限、严重依赖氧气以及治疗剂的非特异性毒性。在这里,基于嵌入可酸解沸石咪唑酯骨架-8(ZIF-8)中的葡萄糖氧化酶(GOx)和超小过氧化物酶纳米酶的级联反应,设计了这样一种肿瘤激活型超小纳米酶发生器,以增强穿透能力和进行深层催化治疗。在轻度酸性的肿瘤微环境中,肿瘤内葡萄糖产生的葡萄糖酸可以逐渐诱导 ZIF-8 的解离,释放出具有显著肿瘤内穿透能力的超小过氧化物酶纳米酶。另一方面,生成的具有相对长寿命的过氧化氢可以被穿透的过氧化物酶纳米酶进一步催化成有毒的羟基自由基,以进行深层催化治疗。通过这种方式,精心设计的纳米平台不仅可以大大增强肿瘤穿透能力,而且可以直接诱导外源性 ROS,无需氧气参与和外部能量输入,从而彻底避免传统基于 ROS 的纳米制剂在极度缺氧的肿瘤中心失活,最终实现显著的深层催化治疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验